|
|
Volumn 16, Issue 6, 2015, Pages e262-
|
|
Correction to Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial [Lancet Oncol (2015) 16: 522-30]
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ERRATUM;
ERROR;
PRIORITY JOURNAL;
|
|
EID: 85119161166
PISSN: 14702045
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/S1470-2045(15)70271-8 Document Type: Erratum |
|
Times cited : (9)
|
|
References (0)
|